Cargando…

SARS‐CoV‐2 infection in pregnancy during the first wave of COVID‐19 in the Netherlands: a prospective nationwide population‐based cohort study (NethOSS)

OBJECTIVE: To describe characteristics, risk factors and maternal, obstetric and neonatal outcomes of pregnant women infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). DESIGN: Multi‐centre prospective population‐based cohort study. SETTING: Nationwide study in the Netherland...

Descripción completa

Detalles Bibliográficos
Autores principales: Overtoom, EM, Rosman, AN, Zwart, JJ, Vogelvang, TE, Schaap, TP, van den Akker, T, Bloemenkamp, KWM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652526/
https://www.ncbi.nlm.nih.gov/pubmed/34494694
http://dx.doi.org/10.1111/1471-0528.16903
_version_ 1784611595941314560
author Overtoom, EM
Rosman, AN
Zwart, JJ
Vogelvang, TE
Schaap, TP
van den Akker, T
Bloemenkamp, KWM
author_facet Overtoom, EM
Rosman, AN
Zwart, JJ
Vogelvang, TE
Schaap, TP
van den Akker, T
Bloemenkamp, KWM
author_sort Overtoom, EM
collection PubMed
description OBJECTIVE: To describe characteristics, risk factors and maternal, obstetric and neonatal outcomes of pregnant women infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). DESIGN: Multi‐centre prospective population‐based cohort study. SETTING: Nationwide study in the Netherlands. POPULATION: Pregnant women with confirmed SARS‐CoV‐2 infection admitted to hospital or in home‐isolation: 1 March 2020 to 31 August 2020. METHODS: Pregnant women with positive polymerase chain reaction or antibody tests were registered using the Netherlands Obstetrics Surveillance System (NethOSS). (Selective) testing occurred according to national guidelines. Data from the national birth registry (pregnant pre‐coronavirus disease 2019 [COVID‐19] cohort) and an age‐matched cohort of COVID‐19‐positive women (National Institute for Public Health and the Environment; fertile age COVID‐19 cohort) were used as reference. MAIN OUTCOME MEASURES: Incidence of SARS‐CoV‐2 infection in pregnant women. Maternal, obstetric and neonatal outcomes including hospital and intensive care admission. RESULTS: Of 376 registered pregnant women with confirmed SARS‐CoV‐2 infection, 20% (74/376) were admitted to hospital, of whom 84% (62/74) were due to SARS‐CoV‐2; 10% (6/62) were admitted to intensive care and 15% (9/62) to obstetric high‐care units. Risk factors for admission were non‐European country of origin (odds ratio [OR] 1.73, 95% CI 1.01–2.96) and being overweight/obese (OR 1.86, 95% CI 1.51–3.20). No maternal or perinatal deaths occurred. Caesarean section after labour‐onset was increased (OR 1.58, 95% CI 1.09–2.28). Hospital and intensive care admission were higher compared with the fertile age COVID‐19 cohort (OR 6.75, 95% CI 5.18–8.81 and OR 2.52, 95% CI 1.11–5.77, respectively). CONCLUSIONS: Non‐European country of origin and being overweight/obese are risk factors for severe course of SARS‐CoV‐2 infection in pregnancy, risk of caesarean section and hospital and intensive care unit admission are increased. TWEETABLE ABSTRACT: Pregnant women with SARS‐CoV‐2 in the Netherlands show increased hospital/ICU admission and caesarean section.
format Online
Article
Text
id pubmed-8652526
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86525262021-12-08 SARS‐CoV‐2 infection in pregnancy during the first wave of COVID‐19 in the Netherlands: a prospective nationwide population‐based cohort study (NethOSS) Overtoom, EM Rosman, AN Zwart, JJ Vogelvang, TE Schaap, TP van den Akker, T Bloemenkamp, KWM BJOG Research Articles OBJECTIVE: To describe characteristics, risk factors and maternal, obstetric and neonatal outcomes of pregnant women infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). DESIGN: Multi‐centre prospective population‐based cohort study. SETTING: Nationwide study in the Netherlands. POPULATION: Pregnant women with confirmed SARS‐CoV‐2 infection admitted to hospital or in home‐isolation: 1 March 2020 to 31 August 2020. METHODS: Pregnant women with positive polymerase chain reaction or antibody tests were registered using the Netherlands Obstetrics Surveillance System (NethOSS). (Selective) testing occurred according to national guidelines. Data from the national birth registry (pregnant pre‐coronavirus disease 2019 [COVID‐19] cohort) and an age‐matched cohort of COVID‐19‐positive women (National Institute for Public Health and the Environment; fertile age COVID‐19 cohort) were used as reference. MAIN OUTCOME MEASURES: Incidence of SARS‐CoV‐2 infection in pregnant women. Maternal, obstetric and neonatal outcomes including hospital and intensive care admission. RESULTS: Of 376 registered pregnant women with confirmed SARS‐CoV‐2 infection, 20% (74/376) were admitted to hospital, of whom 84% (62/74) were due to SARS‐CoV‐2; 10% (6/62) were admitted to intensive care and 15% (9/62) to obstetric high‐care units. Risk factors for admission were non‐European country of origin (odds ratio [OR] 1.73, 95% CI 1.01–2.96) and being overweight/obese (OR 1.86, 95% CI 1.51–3.20). No maternal or perinatal deaths occurred. Caesarean section after labour‐onset was increased (OR 1.58, 95% CI 1.09–2.28). Hospital and intensive care admission were higher compared with the fertile age COVID‐19 cohort (OR 6.75, 95% CI 5.18–8.81 and OR 2.52, 95% CI 1.11–5.77, respectively). CONCLUSIONS: Non‐European country of origin and being overweight/obese are risk factors for severe course of SARS‐CoV‐2 infection in pregnancy, risk of caesarean section and hospital and intensive care unit admission are increased. TWEETABLE ABSTRACT: Pregnant women with SARS‐CoV‐2 in the Netherlands show increased hospital/ICU admission and caesarean section. John Wiley and Sons Inc. 2021-09-26 2022-01 /pmc/articles/PMC8652526/ /pubmed/34494694 http://dx.doi.org/10.1111/1471-0528.16903 Text en © 2021 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Overtoom, EM
Rosman, AN
Zwart, JJ
Vogelvang, TE
Schaap, TP
van den Akker, T
Bloemenkamp, KWM
SARS‐CoV‐2 infection in pregnancy during the first wave of COVID‐19 in the Netherlands: a prospective nationwide population‐based cohort study (NethOSS)
title SARS‐CoV‐2 infection in pregnancy during the first wave of COVID‐19 in the Netherlands: a prospective nationwide population‐based cohort study (NethOSS)
title_full SARS‐CoV‐2 infection in pregnancy during the first wave of COVID‐19 in the Netherlands: a prospective nationwide population‐based cohort study (NethOSS)
title_fullStr SARS‐CoV‐2 infection in pregnancy during the first wave of COVID‐19 in the Netherlands: a prospective nationwide population‐based cohort study (NethOSS)
title_full_unstemmed SARS‐CoV‐2 infection in pregnancy during the first wave of COVID‐19 in the Netherlands: a prospective nationwide population‐based cohort study (NethOSS)
title_short SARS‐CoV‐2 infection in pregnancy during the first wave of COVID‐19 in the Netherlands: a prospective nationwide population‐based cohort study (NethOSS)
title_sort sars‐cov‐2 infection in pregnancy during the first wave of covid‐19 in the netherlands: a prospective nationwide population‐based cohort study (nethoss)
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652526/
https://www.ncbi.nlm.nih.gov/pubmed/34494694
http://dx.doi.org/10.1111/1471-0528.16903
work_keys_str_mv AT overtoomem sarscov2infectioninpregnancyduringthefirstwaveofcovid19inthenetherlandsaprospectivenationwidepopulationbasedcohortstudynethoss
AT rosmanan sarscov2infectioninpregnancyduringthefirstwaveofcovid19inthenetherlandsaprospectivenationwidepopulationbasedcohortstudynethoss
AT zwartjj sarscov2infectioninpregnancyduringthefirstwaveofcovid19inthenetherlandsaprospectivenationwidepopulationbasedcohortstudynethoss
AT vogelvangte sarscov2infectioninpregnancyduringthefirstwaveofcovid19inthenetherlandsaprospectivenationwidepopulationbasedcohortstudynethoss
AT schaaptp sarscov2infectioninpregnancyduringthefirstwaveofcovid19inthenetherlandsaprospectivenationwidepopulationbasedcohortstudynethoss
AT vandenakkert sarscov2infectioninpregnancyduringthefirstwaveofcovid19inthenetherlandsaprospectivenationwidepopulationbasedcohortstudynethoss
AT bloemenkampkwm sarscov2infectioninpregnancyduringthefirstwaveofcovid19inthenetherlandsaprospectivenationwidepopulationbasedcohortstudynethoss